Patent · US Active

RSV-specific antibodies and functional parts thereof

US10689437B2 · kind B2 · utility

4Cited by
10References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 8, 2018
Grant dateJun 23, 2020
Priority date
Expiry dateJun 8, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/90
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This application provides antibodies and functional equivalents thereof which are capable of specifically binding RSV, as well as means and methods for producing them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.